<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-topic" /><meta name="keywords" content="Angina: stable; Angina: management: beta-blockers; Beta-adrenoceptor blocking drugs: angina; Angina: management: calcium-channel blockers; Calcium-channel blockers: angina; Angina: management: nitrates; Nitrates: angina; Ivabradine: angina; Nicorandil: angina; Ranolazine: angina" /><meta name="IX" content="Angina: stable; Angina: management: beta-blockers; Beta-adrenoceptor blocking drugs: angina; Angina: management: calcium-channel blockers; Calcium-channel blockers: angina; Angina: management: nitrates; Nitrates: angina; Ivabradine: angina; Nicorandil: angina; Ranolazine: angina" /><title>Management of stable angina: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP1562-management-of-stable-angina.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP1562-management-of-stable-angina.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP1562-management-of-stable-angina.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 06 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP747-cardiovascular-system.htm">2 Cardiovascular system</a> &gt; <a href="PHP1559-stable-angina-acute-coronary-syndromes-and-fibrinolysis.htm">2.10 Stable angina, acute coronary syndromes, and fibrinolysis</a> &gt; <a href="PHP1560-management-of-stable-angina-and-acute-coronary-syndromes.htm">2.10.1 Management of stable angina and acute coronary syndromes</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP1561-stable-angina.htm" title="Previous: Stable angina">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP1563-acute-coronary-syndromes.htm" title="Next: Acute coronary syndromes">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1>Management of stable angina</h1><?highlighter on?><div id="pC" class="jN"><p>Acute attacks of stable angina should be managed with sublingual <strong>glyceryl trinitrate</strong> (<a title="BNF:monograph: GLYCERYL TRINITRATE" href="PHP1258-glyceryl-trinitrate.htm">section 2.6.1</a>); sublingual glyceryl trinitrate can also be taken immediately before performing activities that are known to bring on an attack. If attacks occur more than twice a week, regular drug therapy is required and should be introduced in a step-wise manner according to response.</p><p>Patients with stable angina should be given a <strong>beta-blocker</strong> (<a title="section: Beta-adrenoceptor blocking drugs" href="PHP934-beta-adrenoceptor-blocking-drugs.htm">section 2.4</a>) or a <strong>calcium-channel blocker</strong> (<a title="BNF:sub-section: Calcium-channel blockers" href="PHP1309-calcium-channel-blockers.htm">section 2.6.2</a>). In those with left-ventricular dysfunction, beta-blocker treatment should be started at a very low dose and titrated very slowly over a period of weeks or months (<a title="topic: Heart failure" href="PHP1123-heart-failure.htm">section 2.5.5</a>); the rate-limiting calcium-channel blockers, diltiazem and verapamil, are contra-indicated in patients with left-ventricular dysfunction because they may precipitate heart failure. If a beta-blocker or a calcium-channel blocker alone fails to control symptoms adequately, a combination of a beta-blocker and a dihydropyridine calcium-channel blocker (e.g. amlodipine, felodipine, modified-release nifedipine) should be used; if this combination is not appropriate due to intolerance of, or contra-indication to, <em>either</em> beta-blockers <em>or</em> calcium-channel blockers, addition of a long-acting <strong>nitrate</strong> (<a title="BNF:sub-section: Nitrates" href="PHP1256-nitrates.htm">section 2.6.1</a>), <strong>ivabradine</strong>, <strong>nicorandil</strong>, or <strong>ranolazine</strong> (<a title="BNF:sub-section: Other antianginal drugs" href="PHP1384-other-antianginal-drugs.htm">section 2.6.3</a>) can be considered.</p><p>For those patients in whom both beta-blockers <em>and</em> calcium-channel blockers are not tolerated or are contra-indicated, monotherapy with a long-acting nitrate, ivabradine, nicorandil, or ranolazine should be considered.</p><p>Response to treatment should be assessed every 2–4 weeks after initiating or changing drug therapy; the drug should be titrated (according to symptom control) to the maximum tolerated dose. Consider referring the patient to a specialist if a combination of two drugs fails to control symptoms. Addition of a third antianginal drug should only be considered if symptom control is not achieved with two drugs and the patient is either due to undergo a revascularisation procedure, or a revascularisation procedure is considered inappropriate. See <a title="BNF:target-block: Antiplatelet drugs in coronary stenting" href="PHP1519-antiplatelet-drugs.htm#PHP1523">section 2.9</a> for the use of antiplatelet drugs in patients undergoing coronary stenting.</p><p>For long-term prevention of cardiovascular events, see <a title="BNF:target-block: prevention of cardiovascular events" href="PHP1564-management-of-unstable-angina-and-non-st-segment-elevation-myocardial-infarction-nstemi.htm#PHP1565">Prevention of cardiovascular events</a>.</p></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP1561-stable-angina.htm">Previous: Stable angina</a> | <a class="top" href="PHP1562-management-of-stable-angina.htm#">Top</a> | <a accesskey="]" href="PHP1563-acute-coronary-syndromes.htm">Next: Acute coronary syndromes</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>